7月 2026
- 首頁
- Contatti Medical
7月 2026Contatti Medical的市場佔有率分析
Pacientes infectados pelo COVID-19, quando apresentam quadro grave, uma resposta hiperinflamatória pode ocorrer tornando-se fatal se não tratada corretamente.
Contatti Medical(包含公司地區)
查看更多網站流量與參與度資訊- contatti.com.br
Contatti Medical截至 7月 2026 的總收入為 10M - 15M
Contatti Medical 熱門網域產生的總收入
Contatti Medical 熱門網域 3 年內的總收入
Contatti Medical 熱門網域的總收入
Contatti Medical的熱門網域總造訪量
了解Contatti Medical市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Contatti Medical的熱門網域平均造訪時長
分析Contatti Medical參與度指標。
過去 3 個月平均造訪時長
子公司細目
Contatti Medical的熱門網域平均頁面瀏覽量
了解Contatti Medical如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Contatti Medical
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞XVIVO Perfusion, Inc. partnered with Contatti Medical on Jan 1st '21.# In 2021, XVIVO Perfusion partnered with Contatti Medical (Brazil) to expand its business and gain access to a comprehensive network of transplantation centers in Latin America's largest country, Brazil.
10月 27, 2022閱讀更多
新聞LifeSci Advisors, LLC partners with Contatti Medical.Dr. Phillip Chan, Chief Executive Officer of CytoSorbents stated, "LifeSci Advisors, LLC is pleased to announce the official registration of CytoSorb in Brazil and the launch of its partnership with Contatti Medical to distribute CytoSorb throughout the country.
9月 21, 2020閱讀更多
新聞CytoSorbents Corporation partners with Contatti Medical.CytoSorbents Corporation (NASDAQ: CTSO ), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, expands CytoSorb distribution to Brazil, Colombia and Costa Rica, with Contatti Medical, Service & Medical Colombia, and Nutricare Costa Rica, respectively.
8月 13, 2019閱讀更多
查看所有Contatti Medical信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
